Uriclense 500

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

Vaccinium macrocarpon, Quantity: 500 mg (Equivalent: Vaccinium macrocarpon, Qty 25 g)

MAH:

Arrotex Pharmaceuticals Pty Ltd

pharmaceutical_form:

Tablet, effervescent

composition:

Excipient Ingredients: sodium bicarbonate; tartaric acid; citric acid; sorbitol; saccharin sodium; macrogol 6000; colloidal anhydrous silica

administration_route:

Oral

therapeutic_indication:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support bladder health ; Traditionally used in Western herbal medicine to Helps reduce occurrence of medically diagnosed cystitis ; Maintain/support urinary tract health ; Traditionally used in Western herbal medicine to Maintain/support urinary tract health ; Maintain/support urinary tract function

leaflet_short:

Visual Identification: ;

authorization_status:

Listed

authorization_date:

2020-12-07